Trials / Completed
CompletedNCT07007702
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective, open, monocentric study is to evaluate the clinical efficacy of a new preservative-free combination of trehalose, sodium hyaluronate and NAAGA in 30 patients with chronic dry eye disease and associated ocular surface inflammation. The main question it aims to answer is: \- To assess the improvement of conjunctival hyperemia as well as subjective symptoms in patients with moderate to severe dry eye. Participants will be asked to use T2769 on a daily basis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | T2769 | Preservative-free combination of trehalose, sodium hyaluronate and N-Acetyl Aspartyl Glutamic Acid |
Timeline
- Start date
- 2025-01-27
- Primary completion
- 2025-04-28
- Completion
- 2025-06-30
- First posted
- 2025-06-06
- Last updated
- 2025-09-25
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT07007702. Inclusion in this directory is not an endorsement.